National Institute of Health researchers have reported the largest genomic study of type 2 diabetes (T2D) in sub-Saharan Africans, with data from more than 5,000 individuals from Nigeria, Ghana and Kenya.
Advertisements
diabetes
Could a popular food ingredient raise the risk for diabetes and obesity?
Consumption of propionate, a food ingredient that’s widely used in baked goods, animal feeds, and artificial flavorings, appears to increase levels of several hormones that are associated with risk of obesity and diabetes, according to new research led by Harvard T.H. Chan School of Public Health in collaboration with researchers from Brigham and Women’s Hospital and Sheba Medical Center in Israel.
Gout treatment may help prevent obesity-related type 2 diabetes, suggests small NIH study
The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health. Their study appears in Diabetes, Endocrinology, and Metabolism.
Vegan diet can benefit both health and the environment
There is strong evidence that a plant-based diet is the optimal diet for living a long and healthy life, according to Harvard T.H. Chan School of Public Health nutrition expert Walter Willett.
Gene mutation points to new way to fight diabetes, obesity, heart disease
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
High blood sugar during pregnancy ups risk of mother’s type 2 diabetes, child’s obesity
Mothers with elevated blood glucose during pregnancy – even if not high enough to meet the traditional definition of gestational diabetes – were significantly more likely to have developed type 2 diabetes a decade after pregnancy than their counterparts without high blood glucose.
Two diabetes medications don’t slow progression of type 2 diabetes in youth
NIH-funded study adds to growing evidence that condition is more aggressive in youth. In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body’s ability to… Read More ›
